Download MP4 Video Faculty: Ralph DeFronzo, MD

Ralph DeFronzo, MD, Chief of the Diabetes Division at the University of Texas Health Science Center in San Antonio, explains the MOA of each of the incretin hormones, GIP and GLP-1, and how the GLP-1 analogs can benefit both newly diagnosed and established type 2 diabetes patients.


Subscribe to our video podcast: Itunes Logo 20